CBRS is trading 11.3% down at $201.01 after its first post-IPO earnings report delivered strong revenue growth but disappointed investors on profitability and margins.
- While the company beat revenue estimates and guided for robust top-line growth, its Q2 and full-year gross margin outlook came in well below expectations and key AI peers.
- The disappointing margin forecast has triggered a sharp post-earnings repricing, even as broader market indices trade modestly higher.